Pharmacologically active microcarriers associated with thermosensitive hydrogel as a growth factor releasing biomimetic 3D scaffold for cardiac tissue-engineering

Journal of Controlled Release

Volumn 192, Issue , 2014, Pages 82-94

  Karam, Jean Pierre ^a,b,c   Muscari, Claudio ^b,c   Sindji, Laurence ^a   Bastiat, Guillaume ^a   Bonafè, Francesca ^b,c   Venier Julienne, Marie Claire ^a   Montero Menei, N Claudia ^a  

^a UNIVERSITÉ D'ANGERS   (France)

^b National Institute for Cardiovascular Research INRC   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Adipose derived stem cells; Growth factors; Hydrogel; Myocardial infarction; Pharmacologically active microcarriers

Indexed keywords

BIOMIMETICS; COPOLYMERS; CYTOLOGY; HEART; HYDROGELS; REPAIR; STEM CELLS; TISSUE;

ADIPOSE DERIVED STEM CELLS; GROWTH FACTOR; HEPATOCYTE GROWTH FACTOR; INSULIN-LIKE GROWTH FACTOR; MICROCARRIERS; MYOCARDIAL INFARCTION; POLY(LACTIC-CO-GLYCOLIC ACID); THERMO-SENSITIVE HYDROGEL; 3-D SCAFFOLDS;

SCAFFOLDS (BIOLOGY); HYDROGELS;

COLLAGEN TYPE 2; CYCLIN D1; FATTY ACID BINDING PROTEIN 4; KI 67 ANTIGEN; MICROSPHERE; MYOCYTE ENHANCER FACTOR 2; PHARMACOLOGICALLY ACTIVE MICROCARRIER; POLYGLACTIN; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SCATTER FACTOR; SOMATOMEDIN C; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR NKX2.5; TROPONIN I; UNCLASSIFIED DRUG; HYDROGEL; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; BETA TUBULIN; CD31 ANTIGEN; CONNEXIN 43; DRUG CARRIER; OSTEOCALCIN; PEROXIDASE;

ADIPOSE DERIVED STEM CELL; ARTICLE; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; HEART; HUMAN; HUMAN CELL; HYDROGEL; NUCLEOTIDE SEQUENCE; PRECIPITATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SOLID STATE; TISSUE ENGINEERING; 3T3 CELL LINE; ADIPOSE TISSUE; ANIMAL; BIOMIMETICS; CELL CULTURE; CHEMICAL STRUCTURE; CHEMISTRY; CYTOLOGY; HEART MUSCLE; METABOLISM; MOUSE; PROCEDURES; STEM CELL; TEMPERATURE; TISSUE SCAFFOLD; UMBILICAL VEIN ENDOTHELIAL CELL; DRUG DOSE TITRATION; DRUG RELEASE; ENZYME ACTIVITY; IN VITRO STUDY; MICROENVIRONMENT; PROTEIN EXPRESSION;

ADIPOSE TISSUE; ANIMALS; BIOMIMETICS; CELL DIFFERENTIATION; CELLS, CULTURED; HEPATOCYTE GROWTH FACTOR; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYDROGEL; INSULIN-LIKE GROWTH FACTOR I; LACTIC ACID; MICE; MODELS, MOLECULAR; MYOCARDIUM; NIH 3T3 CELLS; POLYGLYCOLIC ACID; STEM CELLS; TEMPERATURE; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84904873366     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2014.06.052     Document Type: Article

References (73)

1. V. Segers, and R.T. Lee Stem-cell therapy for cardiac disease Nature 451 2008 937 942 (Pubitemid 351301749)
2. E. Marban, and K. Cheng Heart to heart: the elusive mechanism of cell therapy Circulation 2010 121 2010 1981 1984
3. M. Govoni, C. Muscari, C. Guarnieri, and E. Giordano Mechanostimulation protocols for cardiac tissue engineering Biomed. Res. Int. 2013 2013 918640
4. P. Menasché Cardiac cell therapy: lessons from clinical trials J. Mol. Cell. Cardiol. 50 2011 258 265
5. R. Bolli, A.R. Chugh, D. D'Amario, J.H. Loughran, M.F. Stoddard, S. Ikram, G.M. Beache, S.G. Wagner, A. Leri, T. Hosoda, F. Sanada, J.B. Elmore, P. Goichberg, D. Cappetta, N.K. Solankhi, I. Fahsah, D.G. Rokosh, M.S. Slaughter, J. Kajstura, and P. Anversa Cardiac stem cells in patients with ischemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial Lancet 378 2011 1847 1857
6. R.R. Makkar, R.R. Smith, K. Cheng, K. Malliaras, L.E. Thomson, D. Berman, L.S. Czer, L. Marbán, A. Mendizabal, P.V. Johnston, S.D. Russell, K.H. Schuleri, A.C. Lardo, G. Gerstenblith, and E. Marbán Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial Lancet 379 2012 895 904
7. J. Müller-Ehmsen, P. Whittaker, R.A. Kloner, J.S. Dow, T. Sakoda, T.I. Long, P.W. Laird, and L. Kedes Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium J. Mol. Cell. Cardiol. 34 2002 107 116 (Pubitemid 35229976)
8. K.H. Wu, X.M. Mo, Z.C. Han, and B. Zhou Stem cell engraftment and survival in the ischemic heart Ann. Thorac. Surg. 92 2011 1917 1925
9. C. Muscari, F. Bonafè, S. Martin-Suarez, S. Valgimigli, S. Valente, E. Fiumana, F. Fiorelli, G. Rubini, C. Guarnieri, C.M. Caldarera, O. Capitani, G. Arpesella, and G. Pasquinelli Restored perfusion and reduced inflammation in the infarcted heart after grafting stem cells with a hyaluronan-based scaffold J. Cell. Mol. Med. 17 2013 518 530
10. M.E. Padin-Iruegas, Y. Misao, D.E. Davis, V.F. Segers, G. Esposito, T. Tokunou, K. Urbanek, T. Hosoda, M. Rota, P. Anversa, A. Leri, R.T. Lee, and J. Kajstura Cardiac progenitor cells and biotinylated insulin-like growth factor-1 nanofibers improve endogenous and exogenous myocardial regeneration after infarction Circulation 120 2009 876 887
11. K. Kitta Hepatocyte growth factor induces GATA-4 phosphorylation and cell survival in cardiac muscle cells J. Biol. Chem. 278 2002 4705 4712
12. J.Y. Hahn, H.J. Cho, H.J. Kang, T.S. Kim, M.H. Kim, J.H. Chung, J.W. Bae, B.H. Oh, Y.B. Park, and H.S. Kim Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction J. Am. Coll. Cardiol. 51 2008 933 943
13. G. Forte, M. Minieri, P. Cossa, D. Antenucci, M. Sala, V. Gnocchi, R. Fiaccavento, F. Carotenuto, P. De Vito, P.M. Baldini, M. Prat, and P. Di Nardo Hepatocyte growth factor effects on mesenchymal stem cells: proliferation, migration, and differentiation Stem Cells 24 2006 23 33
14. G. Srinivas, P. Anversa, and W.H. Frishman Cytokines and myocardial regeneration: a novel treatment option for acute myocardial infarction Cardiol. Rev. 17 2009 1 9
15. J. Pons, Y. Huang, J. Arakawa-Hoyt, D. Washko, J. Takagawa, J. Ye, W. Grossman, and H. Su VEGF improves survival of mesenchymal stem cells in infarcted hearts Biochem. Biophys. Res. Commun. 376 2008 419 422
16. C. Muscari, E. Giordano, F. Bonafè, M. Govoni, and C. Guarnieri Strategies affording prevascularized cell-based constructs for myocardial tissue engineering Stem Cells Int 2014 434169 10.1155/2014/434169
17. C. Borselli, H. Storrie, F. Benesch-Lee, D. Shvartsman, C. Cezar, J.W. Lichtman, H.H. Vandenburgh, and D.J. Mooney Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factors Proc. Natl. Acad. Sci. U. S. A. 107 2010 3287 3292
18. J. Saif, T.M. Schwarz, D.Y. Chau, J. Henstock, P. Sami, S.F. Leicht, P.C. Hermann, S. Alcala, F. Mulero, K.M. Shakesheff, C. Heeschen, and A. Aicher Combination of injectable multiple growth factor-releasing scaffolds and cell therapy as an advanced modality to enhance tissue neovascularisation Arterioscler. Thromb. Vasc. Biol. 30 2010 1897 1904
19. S. Banquet, E. Gomez, L. Nicol, F. Edwards-Lévy, J.P. Henry, R. Cao, D. Schapman, B. Dautreaux, F. Lallemand, F. Bauer, Y. Cao, C. Thuillez, P. Mulder, V. Richard, and E. Brakenhielm Arteriogenic therapy by intramyocardial sustained delivery of a novel growth factor combination prevents chronic heart failure Circulation 124 2011 1059 1069
20. Y. Hong, C. Gao, Y. Xie, Y. Gong, and J. Shen Collagen-coated polylactide microspheres as chondrocyte microcarriers Biomaterials 26 2005 6305 6313 (Pubitemid 40828386)
21. E. Garbayo, A.P. Raval, K.M. Curtis, D. Della-Morte, L.A. Gomez, G. D'Ippolito, T. Reiner, C. Perez-Stable, G.A. Howard, M.A. Perez-Pinzon, C.N. Montero-Menei, and P.C. Schiller Neuroprotective properties of marrow-isolated adult multilineage-inducible cells in rat hippocampus following global cerebral ischemia are enhanced when complexed to biomimetic microcarriers J. Neurochem. 119 2011 972 988
22. G.J. Delcroix, E. Garbayo, L. Sindji, O. Thomas, C. Vanpouille-Box, P.C. Schiller, and C.N. Montero-Menei The therapeutic potential of human multipotent mesenchymal stromal cells combined with pharmacologically active microcarriers transplanted in hemi-parkinsonian rats Biomaterials 32 2011 1560 1573
23. R. Pankov, and K.M. Yamada Fibronectin at a glance J. Cell Sci. 115 2002 3861 3863 (Pubitemid 35256486)
24. A. van Dijk, H.W. Niessen, B. Zandieh Doulabi, F.C. Visser, and F.J. van Milligen Differentiation of human adipose-derived stem cells towards cardiomyocytes is facilitated by laminin Cell Tissue Res. 334 2008 457 467
25. V.M. Tatard, M.C. Venier-Julienne, P. Saulnier, E. Prechter, J.P. Benoit, P. Menei, and C.N. Montero-Menei Pharmacologically active microcarriers: a tool for cell therapy Biomaterials 26 2005 3727 3737 (Pubitemid 40038168)
26. C. Bouffi, O. Thomas, C. Bony, A. Giteau, M.C. Venier-Julienne, C. Jorgensen, C. Montero-Menei, and D. Noël The role of pharmacologically active microcarriers releasing TGF-beta3 in cartilage formation in vivo by mesenchymal stem cells Biomaterials 31 2010 6485 6493
27. M. Morille, T. Van-Thanh, X. Garric, J. Cayon, J. Coudane, D. Noël, M.C. Venier-Julienne, and C.N. Montero-Menei New PLGA-P188-PLGA matrix enhances TGF-β3 release from pharmacologically active microcarriers and promotes chondrogenesis of mesenchymal stem cells J. Control. Release 170 2013 99 110
28. C. Musilli, J.P. Karam, S. Paccosi, C. Muscari, A. Mugelli, C.N. Montero-Menei, and A. Parenti Pharmacologically active microcarriers for endothelial progenitor cell support and survival Eur. J. Pharm. Biopharm. 81 2012 609 616
29. A. Giteau, M.C. Venier-Julienne, S. Marchal, J.L. Courthaudon, M. Sergent, C. Montero-Menei, J.M. Verdier, and J.P. Benoit Reversible protein precipitation to ensure stability during encapsulation within PLGA microspheres Eur. J. Pharm. Biopharm. 70 2008 127 136
30. V.T. Tran, J.P. Karam, X. Garric, J. Coudane, J.P. Benoît, C.N. Montero-Menei, and M.C. Venier-Julienne Protein-loaded PLGA-PEG-PLGA microspheres: a tool for cell therapy Eur. J. Pharm. Sci. 45 2012 128 137
31. A. Paillard-Giteau A, V.T. Tran, O. Thomas, X. Garric, J. Coudane, S. Marchal, I. Chourpa, J.P. Benoît, C.N. Montero-Menei, and M.C. Venier-Julienne Effect of various additives and polymers on lysozyme release from PLGA microspheres prepared by an s/o/w emulsion technique Eur. J. Pharm. Biopharm. 75 2010 128 136
32. Z. Li, T.X. Gu, and Y.H. Zhang Hepatocyte growth factor combined with insulin like growth factor-1 improves expression of GATA-4 in mesenchymal stem cells cocultured with cardiomyocytes Chin. Med. J. (Engl.) 121 2008 336 340 (Pubitemid 351479651)
33. G. Lu, H.K. Haider, S. Jiang, and M. Ashraf Sca-1 + stem cell survival and engraftment in the infarcted heart: dual role for preconditioning-induced connexin-43 Circulation 119 2009 2587 2596
34. K. Urbanek, M. Rota, S. Cascapera, C. Bearzi, A. Nascimbene, A. De Angelis, T. Hosoda, S. Chimenti, M. Baker, F. Limana, D. Nurzynska, D. Torella, F. Rotatori, R. Rastaldo, E. Musso, F. Quaini, A. Leri, J. Kajstura, and P. Anversa Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival Circ. Res. 97 2005 663 673 (Pubitemid 41416335)
35. G.M. Ellison, D. Torella, S. Dellegrottaglie, C. Perez-Martinez, A. Perez de Prado, C. VICinanza, S. Purushothaman, V. Galuppo, C. Iaconetti, C.D. Waring, A. Smith, M. Torella, C. Cuellas Ramon, J.M. Gonzalo-Orden, V. Agosti, C. Indolfi, M. Galiñanes, F. Fernandez-Vazquez, and B. Nadal-Ginard Endogenous cardiac stem cell activation by insulin-like growth factor-1/hepatocyte growth factor intracoronary injection fosters survival and regeneration of the infarcted pig heart J. Am. Coll. Cardiol. 58 2011 977 986
36. L. Bocchi, M. Savi, G. Graiani, S. Rossi, A. Agnetti, F. Stillitano, C. Lagrasta, S. Baruffi, R. Berni, C. Frati, M. Vassalle, U. Squarcia, E. Cerbai, E. Macchi, D. Stilli, F. Quaini, and E. Musso Growth factor-induced mobilization of cardiac progenitor cells reduces the risk of arrhythmias, in a rat model of chronic myocardial infarction PLoS One 6 2011 e17750
37. G. Dumortier, J.L. Grossiord, F. Agnely, and J.C. Chaumeil A review of poloxamer 407 pharmaceutical and pharmacological characteristics Pharm. Res. 23 2006 2709 2728 (Pubitemid 44885361)
38. E. Ruel-Gariépy, and J.C. Leroux In situ-forming hydrogels - review of temperature-sensitive systems Eur. J. Pharm. Biopharm. 58 2004 409 426 (Pubitemid 39037244)
39. A. Pasini, F. Bonafè, M. Govoni, C. Guarnieri, P.G. Morselli, H.S. Sharma, C.M. Caldarera, C. Muscari, and E. Giordano Epigenetic signature of early cardiac regulatory genes in native human adipose-derived stem cells Cell Biochem. Biophys. 67 2013 255 262
40. J. Vandesompele, K. De Preter, F. Pattyn, B. Poppe, N. Van Roy, A. De Paepe, and F. Speleman Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes Genome Biol. 3 2002 (RESEARCH0034)
41. A. Linke, P. Müller, D. Nurzynska, C. Casarsa, D. Torella, A. Nascimbene, C. Castaldo, S. Cascapera, M. Böhm, F. Quaini, K. Urbanek, A. Leri, T.H. Hintze, J. Kajstura, and P. Anversa Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function Proc. Natl. Acad. Sci. U. S. A. 102 2005 66 71
42. J.P. Karam, C. Muscari, and C.N. Montero-Menei Combining adult stem cells and polymeric deVICes for tissue engineering in infarcted myocardium Biomaterials 33 2012 5683 5695
43. M.E. Davis, P.C. Hsieh, T. Takahashi, Q. Song, S. Zhang, R.D. Kamm, A.J. Grodzinsky, P. Anversa, and R.T. Lee Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction Proc. Natl. Acad. Sci. U. S. A. 103 2006 8155 8160 (Pubitemid 43801068)
44. X.H. Chen, S. Minatoguchi, K. Kosai, K. Yuge, T. Takahashi, M. Arai, N. Wang, Y. Misao, C. Lu, H. Onogi, H. Kobayashi, S. Yasuda, M. Ezaki, H. Ushikoshi, G. Takemura, T. Fujiwara, and H. Fujiwara In vivo hepatocyte growth factor gene transfer reduces myocardial ischemia-reperfusion injury through its multiple actions J. Card. Fail. 13 2007 874 883 (Pubitemid 350198932)
45. M.S. Penn, and U. Agarwal IGF-1 and mechanisms of myocardial repair Int. J. Cardiol. 38 2010 1 2
46. E. Ruvinov, J. Leor, and S. Cohen The promotion of myocardial repair by the sequential delivery of IGF-1 and HGF from an injectable alginate biomaterial in a model of acute myocardial infarction Biomaterials 32 2011 565 578
47. T.D. Johnson, and K.L. Christman Injectable hydrogel therapies and their delivery strategies for treating myocardial infarction Expert Opin. Drug Deliv. 10 2013 59 72
48. R. Censi, P. Di Martino, T. Vermonden, and W.E. Hennink Hydrogels for protein delivery in tissue engineering J. Control. Release 161 2012 680 692
49. J.P. Karam, F. Bonafè, C. Muscari, and C.N. Montero-Menei Adipose-derived stem cell adhesion on laminin-coated microcarriers improves commitment toward the cardiomyogenic lineage J. Biomed. Mater. Res. Part A 2014 (submitted for publication)
50. C. Pérez, I.J. Castellanos, H.R. Costantino, W. Al-Azzam, and K. Griebenow Recent trends in stabilizing protein structure upon encapsulation and release from bioerodible polymers J. Pharm. Pharmacol. 54 2002 301 313 (Pubitemid 34232331)
51. A.L. Lewis, and L. Illum Formulation strategies for sustained release of proteins Ther. Deliv. 1 2010 457 479
52. L. Wang, Y. Liu, W. Zhang, X. Chen, T. Yang, and G. Ma Microspheres and microcapsules for protein delivery: strategies of drug activity retention Curr. Pharm. Des. 19 2013 6340 6352
53. A. Giteau, M.C. Venier-Julienne, A. Aubert-Pouëssel, and J.P. Benoit How to achieve sustained and complete protein release from PLGA-based microparticles? Int. J. Pharm. 350 2008 14 26
54. C. Penna, M.G. Perrelli, J.P. Karam, C. Angotti, C. Muscari, C.N. Montero-Menei, and P. Pagliaro Pharmacologically active microcarriers influence VEGF-A effects on mesenchymal stem cell survival J. Cell. Mol. Med. 17 2013 192 204
55. E. Ruvinov, J. Leor, and S. Cohen The effects of controlled HGF delivery from an affinity-binding alginate biomaterial on angiogenesis and blood perfusion in a hindlimb ischemia model Biomaterials 31 2010 4573 4582
56. C. Roggia, C. Ukena, M. Böhm, and H. Kilter Hepatocyte growth factor (HGF) enhances cardiac commitment of differentiating embryonic stem cells by activating PI3 kinase Exp. Cell Res. 313 2007 921 930
57. S.J. Huang, R.H. Fu, W.C. Shyu, S.P. Liu, G.P. Jong, Y.W. Chiu, H.S. Wu, Y.A. Tsou, C.W. Cheng, and S.Z. Lin Adipose-derived stem cells: isolation, characterization, and differentiation potential Cell Transplant. 22 2013 701 709
58. B. Schwanhäusser, D. Busse, N. Li, G. Dittmar, J. Schuchhardt, J. Wolf, W. Chen, and M. Selbach Global quantification of mammalian gene expression control Nature 473 2011 337 342
59. R. Lu, F. Markowetz, R.D. Unwin, J.T. Leek, F.M. Airoldi, B.D. MacArthur, A. Lachmann, R. Rozov, and A. Ma'ayan Systems-level dynamic analyses of fate change in murine embryonic stem cells Nature 462 2009 358 362
60. B. Thurisch, S.Y. Liang, N. Sarioglu, L. Schomburg, J. Bungert, and C. Dame Transgenic mice expressing small interfering RNA against Gata4 point to a crucial role of Gata4 in the heart and gonads J. Mol. Endocrinol. 43 2009 157 169
61. R. Di Lisi, C. Millino, E. Calabria, F. Altruda, S. Schiaffino, and S. Ausoni Combinatorial cis-acting elements control tissue-specific activation of the cardiac troponin I gene in vitro and in vivo J. Biol. Chem. 273 1998 (25371-15380)
62. P.K. Bhavsar, K.A. Dellow, M.H. Yacoub, N.-J. Brand, and P.J. Barton Identification of cis-acting DNA elements required for expression of the human cardiac troponin I gene promoter J. Mol. Cell. Cardiol. 32 2000 95 108 (Pubitemid 30064308)
63. R.M. Day, L. Soon, D. Breckenridge, B. Bridges, B.K. Patel, L.M. Wang, S.J. Corey, and D.P. Bottaro Mitogenic synergy through multilevel convergence of hepatocyte growth factor and interleukin-4 signaling pathways Oncogene 21 2002 2201 2211 (Pubitemid 34311374)
64. H. Yu, and T. Rohan Role of the insulin-like growth factor family in cancer development and progression J. Natl. Cancer Inst. 92 2000 1472 1489
65. J.R. Tse, and A.J. Engler Stiffness gradients mimicking in vivo tissue variation regulate mesenchymal stem cell fate PLoS One 6 2011 e15978
66. G.C. Reilly, and A.J. Engler Intrinsic extracellular matrix properties regulate stem cell differentiation J. Biomech. 43 2010 55 62
67. A.J. Engler, S. Sen, H.L. Sweeney, and D.E. Discher Matrix elasticity directs stem cell lineage specification Cell 126 2006 677 689 (Pubitemid 44233625)
68. Z. Li, X. Guo, A.F. Palmer, H. Das, and J. Guan High-efficiency matrix modulus-induced cardiac differentiation of human mesenchymal stem cells inside a thermosensitive hydrogel Acta Biomater. 8 2012 3586 3595
69. E.A. Klein, L. Yin, D. Kothapalli, P. Castagnino, F.J. Byfield, T. Xu, I. Levental, E. Hawthorne, P.A. Janmey, and R.K. Assoian Cell-cycle control by physiological matrix elasticity and in vivo tissue stiffening Curr. Biol. 19 2009 1511 1518
70. N.S. Peters New insights into myocardial arrhythmogenesis: distribution of gap-junctional coupling in normal, ischaemic and hypertrophied human hearts Clin. Sci. (Lond.) 90 1996 447 452 (Pubitemid 26177196)
71. H.S. Duffy Cardiac connections - the antiarrhythmic solution? N. Engl. J. Med. 358 2008 1397 1398
72. S. Fernandes, H.V. van Rijen, V. Forest, S. Evain, A.L. Leblond, J. Mérot, F. Charpentier, J.M. de Bakker, and P. Lemarchand Cardiac cell therapy: overexpression of connexin43 in skeletal myoblasts and prevention of ventricular arrhythmias J. Cell. Mol. Med. 13 2009 3703 3712
73. G. Hawat, P. Hélie, and G. Baroudi Single intravenous injection of connexin 43 mimetic peptides protect ischemic heart in vivo against myocardial infarction J. Mol. Cell. Cardiol. 53 2012 559 566